^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    AEBP1 expression

    i
    Other names: AEBP1, AE Binding Protein 1, Aortic Carboxypeptidase-Like Protein, Adipocyte Enhancer-Binding Protein 1, AE-Binding Protein 1, ACLP, Adipocyte Enhancer Binding Protein 1
    Entrez ID:
    165
    Related biomarkers:
    Expression
    20d
    Arenobufagin Induces Ferroptosis in Glioblastoma Cells via Modulating the MiR-149-5p/AEBP1 Axis. (PubMed, J Appl Toxicol)
    This study revealed that ArBu induced ferroptosis in a dose-dependent manner via modulating miR-149-5p/AEBP1 axis. It provides evidences for clinical application of ArBu for GBM.
    Journal
    |
    AEBP1 (AE Binding Protein 1) • MIR149 (MicroRNA 149)
    |
    AEBP1 expression
    8ms
    AEBP1 upregulation contributes to cervical cancer progression by facilitating cell proliferation, migration, and invasion. (PubMed, J Obstet Gynaecol Res)
    This study suggested that AEBP1 acts as an oncogened and might be a potential therapeutic target for the treatment of cervical cancer.
    Journal
    |
    STAT3 (Signal Transducer And Activator Of Transcription 3) • AEBP1 (AE Binding Protein 1)
    |
    AEBP1 overexpression • AEBP1 expression
    11ms
    AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling. (PubMed, Neoplasia)
    Over-expression of BMP4 can rescue the inhibitory effects of AEBP1 knockout on the growth, invasion, and EMT phenotype of PTC cells. In conclusion, these findings demonstrated that AEBP1 plays a critical role in PTC progression by regulating BMP4 expression and the AEBP1-BMP4 axis may present novel therapeutic targets for PTC treatment.
    Journal
    |
    AEBP1 (AE Binding Protein 1) • CDH2 (Cadherin 2) • TWIST1 (Twist Family BHLH Transcription Factor 1) • ZEB2 (Zinc Finger E-Box Binding Homeobox 2) • BMP4 (Bone Morphogenetic Protein 4)
    |
    AEBP1 expression
    over1year
    ACLP Activates Cancer-Associated Fibroblasts and Inhibits CD8+ T-Cell Infiltration in Oral Squamous Cell Carcinoma. (PubMed, Cancers (Basel))
    Boyden chamber assays suggested that ACLP in CAFs may attenuate CD8+ T cell migration. Our results suggest that stromal ACLP contributes to the development of OSCCs, and that ACLP is a potential therapeutic target.
    Journal
    |
    CD8 (cluster of differentiation 8) • AEBP1 (AE Binding Protein 1) • TGFB1 (Transforming Growth Factor Beta 1)
    |
    AEBP1 expression
    over1year
    AEBP1 Contributes to Breast Cancer Progression by Facilitating Cell Proliferation, Migration, Invasion, and Blocking Apoptosis. (PubMed, Discov Med)
    In summary, these data suggested the important role of AEBP1 in the BCa progression, which could be used as a potential biomarker for prognostic hallmark and a novel therapeutic strategy.
    Journal • IO biomarker
    |
    PTEN (Phosphatase and tensin homolog) • BCL2 (B-cell CLL/lymphoma 2) • CDH1 (Cadherin 1) • AEBP1 (AE Binding Protein 1) • VIM (Vimentin) • CASP9 (Caspase 9) • CDH2 (Cadherin 2) • SMAD2 (SMAD Family Member 2)
    |
    BCL2 expression • AEBP1 overexpression • CDH1 expression • VIM expression • AEBP1 expression